Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QUOTED. 20 June 2019. Fatta Nahab.

Executive Summary

A new study shows that Global Kinetics' Personal KinetiGraph (PKG) wearable sensor system can identify the best candidates for device-assisted therapies for Parkinson's disease including deep brain stimulation. See what Fatta Nahab, a neurologist at the University of California, San Diego, said about it here.

"Most patients with Parkinson’s are managed by a general neurologist or somebody who is not typically a specialist or expert in managing Parkinson’s, whereas the specialists are usually the ones who determine whether somebody is a good candidate for a device-assisted therapy such as deep-brain stimulation. So that creates a little bit of a disconnect." – Fatta Nahab, neurologist, University of California, San Diego

 

Click here for a free trial of Medtech Insight

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT125268

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel